The growing family of interferon regulatory factors

Cytokine and Growth Factor Reviews

Volumn 8, Issue 4, 1997, Pages 293-312

  Nguyen, Hannah ^a,b   Hiscott, John ^a,b   Pitha, Paula M ^c  

^a MCGILL UNIVERSITY   (Canada)

^b MCGILL UNIVERSITY   (Canada)

^c JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

Gene regulation; Interferon; Signal transduction; Transcription

Indexed keywords

BACTERIAL PROTEIN; DNA BINDING PROTEIN; IFN CONSENSUS SEQUENCE BINDING PROTEIN; INTERFERON; INTERFERON REGULATORY FACTOR-1; INTERFERON REGULATORY FACTOR-2; INTERFERON REGULATORY FACTOR-3; INTERFERON-STIMULATED GENE FACTOR 3; IRF-7 PROTEIN; LYMPHOID-SPECIFIC INTERFERON REGULATORY FACTOR; PHOSPHOPROTEIN; REGULATOR PROTEIN; REPRESSOR PROTEIN; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG; VIR GENE PRODUCTS;

AMINO ACID SEQUENCE; ANIMAL; ANTIVIRAL ACTIVITY; CELL DIVISION; CELL PROLIFERATION; CHEMISTRY; GENE EXPRESSION REGULATION; GENETICS; GROWTH REGULATION; HEMATOPOIESIS; HUMAN; IMMUNITY; IMMUNOMODULATION; INTERFERON PRODUCTION; MOLECULAR GENETICS; MOUSE; NONHUMAN; PHYSIOLOGY; PROTEIN DETERMINATION; REVIEW; SEQUENCE HOMOLOGY; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION;

ANIMALIA; BACTERIA (MICROORGANISMS); VIR;

EID: 0031418944     PISSN: 13596101     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1359-6101(97)00019-1     Document Type: Short Survey

References (112)

1. 1. Vilcek, J. and Sen, G., Interferons and other cytokines. In Virology, B. Fields, D. M. Knipe, and P. M. Howley, editors. Lippincott-Raven, Philadelphia, 375-399.
2. 2. Gutterman, J. U., Cytokine therapeutics: lessons from interferon alpha. Proc. Natl. Acad. Sci. U.S.A., 1994, 91, 1198-1205.
3. 3. Hiscott, J., Nguyen, H. and Lin, R., Molecular mechanisms of interferon beta gene induction. Semin. Virol., 1995, 6, 161-173.
4. 4. Pitha P. M. and Au, W.-C., Induction of interferon alpha gene expression. Semin. Virol., 1995, 6, 151-159.
5. 5. Levy, D. E., Interferon induction of gene expression through the Jak-Stat pathway. Semin. Virol., 1995, 6, 181-190.
6. 6. Schindler, C. and Darnell, Jr. J. E., Transcriptional responses to polypeptide ligands: the JAK-STAT pathway. Ann. Rev. Biochem., 1995, 64, 621-651.
7. 7. Darnell, Jr. K. E., Kerr, I. M. and Stark, G. R., Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins. Science, 1994, 264, 1415-1421.
8. 8. Ihle, J. N., STATs: signal transducers and activators of transcription. Cell, 1996, 84, 331-334.
9. 9. Fujita, T., Sakakibara, J., Sudo, Y., Miyamoto, M., Kimura, Y. and Taniguchi, T., Evidence for a nuclear factor(s), IRF-1, mediating induction and silencing properties to human IFN-β gene regulatory elements. EMBO J, 1988, 7, 3397-3405.
10. 10. Miyamoto, M., Fujita, T., Kimura, Y., Maruyama, M., Harada, H., Sudo, Y., Miyata, T. and Taniguchi, T., Regulated expression of a gene encoding a nuclear factor, IRF-1, that specifically binds to the IFN-β gene regulatory elements. Cell, 1988, 54, 903-913.
11. 11. Fujita, T., Kimura, Y., Miyamoto, M., Barsoumian, E. L. and Taniguchi, T., Induction of endogenous IFN-α and IFN-β genes by a regulatory transcription factor IRF-1. Nature, 1989, 337, 270-272.
12. 12. Harada, H., Fujita, T., Miyamoto, M., Kimura, Y., Maruyama, M. Furia, A., Miyata, T. and Taniguchi, T., Structurally similar but functionally distinct factors, IRF-1 and IRF-2, bind to the same regulatory elements of IFN and IFN-inducible genes. Cell, 1989, 58, 729-739.
13. 13. Veals, S. A., Schindler, C., Leonard, D., Fu, X.-Y., Aebersold, R., Darnell, Jr. J. E. and Levy, D. E., Subunit of an alpha-interferon-responsive transcription factor is related to interferon regulatory factor and myb families of DNA-binding proteins. Mol. Cell. Biol., 1992, 12, 3315-3324.
14. 14. Russo, J. J., Bohenzky, R. A., Chien, M.-C., Chen, J., Yan, M., Maddalena, D., Parry. J. P., Peruzzi, D., Edelman, I. S., Chang, Y. and Moore, P., Nucleotide sequence of the kaposi sarcoma-associated herpesvirus (HHV8). Proc. Natl. Acad. Sci. U.S.A., 1996, 93, 14862-14867.
15. 15. Moore, P. S., Boshoff, C., Weiss, R. A. and Chang, Y., Molecular mimicry of human cytokine and cytokine response pathway genes by KSHV. Science, 1996, 274, 1739-1744.
16. 16. Lamphier, M. and Taniguchi, T., The transcription factors IRF-1 and IRF-2. The Immunologist, 1994, 2, 167-171.
17. 17. Taniguchi, T., Lamphier, M. S. and Tanaka, N., IRF-1: the transcription factor linking the interferon response and oncogenesis. Biochim. Biophys. Acta Rev. Cancer. 1997, 1333, M9-M17.
18. 18. Au, W. C., Su, Y., Raj, N. K. B. and Pitha, P. M., Virus-mediated induction of interferon A gene requires cooperation between multiple binding factors in the interferon alpha promoter region. J. Biol. Chem., 1993, 268, 24032-24040.
19. 19. Fujita, T., Reis, L. F. L., Watanabe, N., Kimura, Y., Taniguchi, T. and Vilcek, J., Induction of the transcription factor IRF-1 and interferon-β mRNAs by cytokines and activators of second-messenger pathways. Proc. Natl. Acad. Sci. U.S.A., 1989, 86, 9936-9940.
20. 20. Abdollahi, A., Lord. K. A., Hoffman-Liebermann, B. and Liebermann, D. A., Interferon regulatory factor 1 is a myeloid differentiation primary response gene induced by interleukin-6 and leukemia inhibitory factor: role in growth inhibition. Cell Growth Differ., 1991, 2, 401-407.
21. 21. Reis, L. F. L., Harada, H., Wolchok, J. D., Taniguchi, T. and Vilcek, J., Critical role of a common transcription factor, IRF-1, in the regulation of IFN-β and IFN-inducible genes. EMBO J., 1992, 11, 185-193.
22. 22. Wang, I.-M., Blanco, J. C. G., Tsai, S. Y., Tsai, M.-J. and Ozato, K., Interferon regulatory factors and TFIIB cooperatively regulate interferon-responsive promoter activity in vivo and in vitro. Mol. Cell. Biol., 1996, 16, 6313-6324.
23. 23. Uegaki, K., Shirakawa, M., Fujita, T., Taniguchi, T. and Kyogoku, Y., Characterization of the DNA binding domain of the mouse IRF-2 protein. Protein Eng., 1993, 6, 195-200.
24. 24. Lin, R., Mustafa, A., Nguyen, H. and Hiscott, J., Mutational analysis of interferon (IFN) regulatory factors 1 and 2: Effects on the induction of IFN-β gene expression. J. Biol. Chem., 1994, 269, 17542-17549.
25. 25. Yamamoto, H., Lamphier, M. S., Fujita, T., Taniguchi, T. and Harada, H., The oncogenic transcription factor IRF-2 possesses a transcriptional repression and a latent activation domain. Oncogene, 1994, 9, 1423-1428.
26. 26. Watanabe, N., Sakakibara, J., Hovanessian, A. G., Taniguchi, T. and Fujita, T., Activation of IFN-β element by IRF-1 requires a post-translational event in addition to IRF-1 synthesis. Nucl. Acid Res., 1991, 19, 4421-4428.
27. 27. Pine, R., Decker, T., Kessler, D. S., Levy, D. E. and Darnell, Jr. J. E., Purification and cloning of interferon-stimulated gene factor 2 (ISGF2): ISGF2 (IRF-1) can bind to the promoters of both beta-interferon-and interferon-stimulated genes but is not a primary transcriptional activator of either. Mol. Cell. Biol., 1990, 10, 2448-2457.
28. 28. Nguyen, H., Mustafa, A., Hiscott, J. and Lin, R., Transcription factor IRF-2 exerts its oncogenic phenotype through the DNA binding/transcription repression domain. Oncogene, 1995, 11, 537-544.
29. 29. Palombella, V. and Maniatis, T., Inducible processing of interferon regulatory factor-2. Mol. Cell. Biol., 1992, 12, 3325-3336.
30. 30. Cohen, L. and Hiscott, J., Characterization of TH3, an induction specific protein interacting with the interferon-β promoter. Virol, 1992, 191, 589-599.
31. 31. Whiteside, S. T., King, P. and Goodbourn, S., A truncated form of the IRF-2 transcription factor has the properties of a postinduction repressor of interferon-β gene expression. J. Biol. Chem., 1994, 269, 27059-27065.
32. 32. Pinna, L. A., Casein kinase II: An 'Eminence grise' in cellular regulation? Biochim. Biophys. Acta, 1990, 1054, 267-284.
33. 33. Harada, H., Kitagawa, M., Tanaka, N., Yamamoto, H., Harada, K., Ishihara, M. and Taniguchi, T., Anti-oncogenic and oncogenic potentials of interferon regulatory factors-1 and -2. Science, 1993, 259, 971-974.
34. 34. Tanaka, N., Ishihara, M. and Taniguchi, T., Suppression of c-myc or fos-B-induced cell transformation by the transcription factor IRF-1. Cancer Lett., 1994, 83, 191-196.
35. 35. Willman, C. L., Sever, C. E., Pallavicini, M. G., Harada, H., Tanaka, N., Slovak, M. L., Yamamoto, H., Harada, K.. Meeker, T. C., List, A. F. and Taniguchi, T., Deletion of IRF-1, mapping to chromosome 5q31.1, in human leukemia and preleukemia myelodysplasias. Science, 1993, 259, 968-971.
36. 36. Harada, H., Kondo, T., Ogawa, S., Tamura, T., Kitagawa, M., Tanaka, N., Lamphier, M. S., Hisamura, H. and Taniguchi, T., Accelerated exon skipping of IRF-1 mRNA in human myelodysplasia/leukemia: a possible mechanism of tumor suppression inactivation. Oncogene, 1994, 9, 3313-3320.
37. 37. Kondo, T., Minamino, N., Nagamura-Inoue, T., Matsumoto, M., Taniguchi, T. and Tanaka, N., Identification and characterization of nucleophosmin/B23/numatrin which binds the anti-oncogenic transcription factor IRF-1 and manifests oncogenic activity. Oncogene, 1997, 15, 1275-1281.
38. 38. Tanaka, N., Ishihara, M., Kitagawa, M., Harada, H., Kimura, T., Matsuyama, T., Lamphier, M. S., Aizawa, S., Mak, T. W. and Taniguchi, T., Cellular commitment to oncogene-induced transformation or apoptosis is dependent on the transcription factor IRF-1. Cell, 1994, 77, 829-839.
39. 39. Kirchoff, S., Koromilas, A. E., Schaper, F., Grashoff, M., Sonenberg, N. and Hauser, H., IRF-1 induced cell growth inhibition and interferon induction requires the activity of the protein kinase PKR. Oncogene, 1995, 11, 439-445.
40. 40. Yang, Y.-L., Reis, L. F. L., Pavlovic, J., Aguzzi, A., Schaefer, R., Kumar, A., Williams, B. R. G., Aguet, M. and Weissman, C., Deficient signalling in mice devoid of double-stranded RNA-dependent protein kinase. EMBO J., 1995, 14, 6095-6106.
41. 41. Kumar, A., Yang, Y.-L., Flati, V., Der, S., Kadereit, S., Deb, A., Haque, J., Reis, L., Weissman, C. and Williams, B. R. G., Deficient cytokine signalling in mouse embryo fibroblasts with a targeted deletion in the PKR gene: role of IRF-1 and NF-κB. EMBO J., 1997, 16, 406-416.
42. 42. Tamura, T., Ishihara, M., Lamphier, M. S., Tanaka, N., Oishi, I., Aizawa, S., Matsuyama, T., Mak, T. W., Taki, S. and Taniguchi, T., An IRF-1-dependent pathway of DNA damage-induced apoptosis in mitogen-activated T-lymphocytes. Nature, 1995, 376, 596-599.
43. 43. Ozawa, H., Matsuyama, T., Mak, T. W., Aizawa, S., Tokino, T., Oren, M. and Taniguchi, T., Cooperation of the tumour suppressors IRF-1 and p53 in response to DNA damage. Nature, 1996, 382, 816-818.
44. 44. Nguyen, H., Lin, R. and Hiscott, J., Activation of multiple growth regulatory genes following inducible expression of IRF-1 or IRF/RelA fusion proteins. Oncogene, 1997, 15, 1425-1435.
45. 45. Tan, R. S., Taniguchi, T. and Harada, H., Identification of the lysyl oxidase gene as target of the antioncogenic transcription factor, IRF-1, and its possible role in tumor suppression. Cancer Res., 1996, 56, 2417-2421.
46. 46. Contente, S., Kenyon, K., Rimoldi, D. and Friedman, R. M., Expression of gene rrg is associated with reversion of NIH3T3 transformed by LTR-c-H-ras. Science, 1990, 249, 796-798.
47. 47. Hajnal, A., Klemenz, R. and Schafer, R., Up-regulation of lysyl oxidase in spontaneous revenants of H-ras-transformed rat fibroblasts. Cancer Res., 1993, 53, 4670-4675.
48. 48. Vaughan, P. S., Aziz, F., van Wijnen, A. J., Wu, S., Harada, H., Taniguchi, T., Soprano, K. J., Stein, J. L. and Stein, G. S., Activation of a cell-cycle-regulated histone gene by the oncogene transcription factor IRF-2. Nature, 1995, 377, 362-365.
49. 49. Nonkwello, C., Ruf, I. K. and Sample, J., Interferon-independent and -induced regulation of Epstein-Barr Virus EBNA-1 gene transcription in Burkitt lymphoma. J. Virol., 1997, 71, 6887-6897.
50. 50. Matsuyama, T., Kimura, T., Kitagawa, M., Watanabe, N., Kundig, T., Amakawa, R., Kishihara, K., Wakeham, A., Potter, J., Furlonger, C., Narendran, A., Suzuki, H., Ohashi, P., Paige, C., Taniguchi, T. and Mak, T., Targeted disruption of IRF-1 or IRF-2 results in abnormal type I IFN induction and aberrant lymphocyte development. Cell, 1993, 75, 83-97.
51. 51. Penninger, J. M. and Mak, T. W., Signal transduction, mitotic catastrophies, and death in T-cell development. Immunol. Rev., 1994, 142, 231-272.
52. + T cells in IRF-1 mice. Immunity, 1996, 5, 365-376.
53. 53. Taki, S., Sato, T., Ogasawara, K., Fukuda, T., Sato, M., Hida, S., Suzuki, G., Mitsuyama, M., Furuta, T., Kojima, S., Taniguchi, T. and Asano, Y., Multistage regulation of Th1-type immune responses by the transcription factor IRF-1. Immunity, 1997, 6, 1-20.
54. 54. Duncan, G. S., Mittrucker, H. W., Kagi, D., Matsuyama, T. and Mak, T. W., The transcription factor Interferon regulatory factor-1 is essential for natural killer cell function in vivo. J. Exp. Med., 1996, 184, 2043-2048.
55. 55. Kamijo, R., Harada, H., Matsuyama, T., Bosland, M., Gerecitano, J., Shapiro, D., Le, J., Koh, S. I., Kimura, T., Green, S. J., Mak, T. W., Taniguchi, T. and Vilcek, J., Requirement for transcription factor IRF-1 in NO synthase induction in macrophages. Science, 1994, 263, 1612-1615.
56. 56. Martin, E., Nathan, C. and Xie, Q., Role of Interferon regulatory factor 1 in induction of nitric oxide synthase. J. Exp. Med., 1994, 80, 977-984.
57. 57. Harada, H., Willison, K., Sakakibara, J., Miyamoto, M., Fujita, T. and Taniguchi, T., Absence of I IFN system in EC cells: transcriptional activator (IRF-1) and represser (1RF-2) genes are developmentally regulated. Cell, 1990, 63, 903-913.
58. 58. Whiteside, S. T., Visvanathan, K. V., Goodbourn, S., Identification of novel factors that bind to the PRDI region of the human β-interferon promoter. Nucl. Acid Res., 1992, 20, 1531-1538s.
59. 59. Au, W.-C., Raj, N. B., Pine, R. and Pitha, P. M., Distinct activation of murine interferon a promoter region by IRF-1/ISGF-2 and virus infection. Nucl. Acid Res., 1992, 20, 2877-2884.
60. 60. Reis, L. F. L., Ruffner, H., Stark, G., Aguet, M. and Weissman, C., Mice devoid of interferon regulatory factor 1 (IRF-1) show normal expression of type I interferon genes. EMBO J., 1994, 13, 4798-4806.
61. 61. Stewart, W. E., Gosser, L. B., Lockart, Jr. R. Z., The effect of priming with interferon on interferon production by two lines of L cells. J. Gen. Virol., 1971, 15, 85-87.
62. 62. Raj, N. B. and Pitha, P. M., Analysis of interferon mRNA in human fibroblast cells induced to produce interferon. Proc. Natl. Acad. Sci. U.S.A., 1981, 78, 7426-7430.
63. 63. Enoch, T., Zinn, K. and Maniatis, T., Activation of the human beta-intereron gene requires an interferon-inducible factor. Mol. Cell. Biol., 1986, 6, 801-810.
64. 64. Dron, M., Lacasa, M. and Tovey, M. G., Priming affects the activity of a specific region of the promoter of the human beta interferon gene. Mol. Cell. Biol., 1990, 10, 854-858.
65. 65. Génin, P., Bragança, J., Darracq, N., Doly, J. and Civas, A., A novel PRDI and TG binding activity involved in virus-induced transcription of IFN-A genes. Nucl. Acid Res., 1995, 23, 5055-5063.
66. 66. Bragança, J., Génin, P., Bandu, M.-T., Darracq, N., Vignal, M., Cassé, C., Doly, J. and Civas, A., Synergism between multiple virus-induced-factor-binding elements involved in the differential expression of IFN-A genes. J. Biol. Chem., 1997, 272, 22154-22162.
67. 67. Kawakami, T., Matsumoto, M., Sato, M., Harada, H., Taniguchi, T. and Kitigawa, M., Possible involvement of the transcription factor ISGF3γ in virus-induced expression of the IFN-β gene. FEBS Lett, 1995, 358, 225-229
68. 68. Kimura, T., Kadokawa, Y., Harada, H., Matsumoto, M., Sato, M., Kashiwazaki, Y., Tarutani, M., Tan, R.S.-P., Takasugi, T., Matsuyama, T., Mak, T. M., Noguchi, S. and Taniguchi, T., Essential and non-redundant roles of p48 (ISGF3γ) and IRF-1 in both type I and type II interferon responses as revealed by gene targeting studies. Genes to Cells, 1996, 1, 115-124.
69. 69. Harada, H., Matsumoto, M., Sato, M., Kashiwazaki, Y., Kimura, T., Kitagawa, M., Yokochi, T., Tan, R.S.-P., Takasugi, T., Kadokawa, Y., Schindler, C., Schreiber, R. D., Noguchi, S. and Taniguchi, T., Regulation of IFN-α/β genes: evidence for a dual fraction of the transcription factor complex ISGF3 in the production and action of IFN-α/β. Genes to Cells, 1996, 1, 995-1005.
70. 70. Yoneyama, M., Suhara, W., Fukuhara, Y., Sato, M., Ozato, K. and Fujita, T., Autocrine amplification of type I interferon gene expression mediated by interferon stimulated gene factor 3 (ISGF3). J. Biochem., 1996, 120, 160-169.
71. 71. Kimura, T., Nakayama, K., Penninger, J., Kitagawa, M., Harada, H., Matsuyama, T., Tanaka, N., Kamijo, R., Vilcek, J., Mak, T. W. and Taniguchi, T., Involvement of the IRF-1 transcription factor in antiviral responses to interferons. Science, 1994, 264, 1921-1924.
72. 72. McKinsey, T. A., Brockman, J. A., Scherer, D. C., AlMurrani, S. W., Green, P. L. and Ballard, D. W., Inactivation of IκBβ by the Tax protein of human T-cell leukemia virus type 1: a potential mechanism for constitutive induction of NF-κB. Mol. Cell. Biol., 1996, 16, 2083-2090.
73. 73. Au, W.-C., Moore, P. A., Lowther, W., Juang, Y.-T. and Pitha, P. M., Identification of a member of the interferon regulatory factor family that binds to the interferon-stimulaled response element and activates expression of interferon-induced genes. Proc. Natl. Acad. Sci. U.S.A., 1995, 92, 11657-11661.
74. 74. Grant, C. E., Vasa, M. Z. and Deeley, R. G., c1RF-3, a new member of the interferon regulatory factor (IRF) family that is rapidly and transiently induced by dsRNA. Nucl. Acids Res., 1995, 23, 2137-2146.
75. 75. Schafer, S. L., Lin, R., Moore, P. A., Hiscott, J. and Pitha, P. M., Regulation of type I inlerferon gene expression by interferon regulatory factor-3. J. Biol. Chem., 1998 (in press).
76. 76. Horvai, A. E., Xu, L., Korzus, Brard, G., Kalafus, D., Mullen, T. M., Rose, D. W., Rosenfeld, M. G. and Glass, C. K., Nuclear integration of JAK/ST AT and RAS/AP-1 signalling by CBP and p300. Proc. Natl. Acad. Sci. U.S.A., 1997, 94, 1074-1079.
77. 77. Zhang, J. J., Vinkemeier, U., Gu, W., Chakravarti, D., Horvath, C. M. and Darnell, J. E., Two contact regions between STAT1 and CBP/p300 in interferon gamma signalling. Proc. Natl. Acad. Sci. U.S.A., 1996, 93, 15092-15096.
78. 78. Eckner, R., p300 and CBP as transcriptional regulators and targets of oncogenic events. Biol. Chem., 1996, 377, 685-688.
79. 79. Bluyssen, H. A. R., Durbin, J. E. and Levy, D. E., ISGF3γ, a specificity switch for interferon activated transcription factors. Cyt. Growth Fact. Rev., 1996, 7, 11-17.
80. 80. Kessler, D. S., Veals, S. A., Fu, X.-Y. and Levy, D. E., Interferon-α regulates nuclear translocation and DNA-binding affinity of ISGF3, a multimeric transcriptional activator. Genes Der., 1990, 4, 1753-1765.
81. 81. Veals, S. A., Santa Maria, T. and Levy, D. E., Two domains of ISGF3γ that mediate protein DNA and protein protein interactions during transcription factor assembly contribute to DNA-binding specificity. Mol. Cell. Biol., 1993, 13, 196-206.
82. 82. Sharf, R., Meraro, D., Azriel, A., Thornton, A. M., Ozato, K., Petricoin, E. E., Larner, A. C., Shaper, F., Hauser, H. and Levi, B.-Z., Phosphorylation events modulate the ability of interferon consensus sequence binding protein to interact with interferon regulatory factors and to bind DNA. J. Biol. Chem., 1997, 272, 9785-9792.
83. 83. John, J., McKendry, R., Pellegrini, S., Flavell, D., Kerr, I. M. and Stark, G. R., Isolation and characterization of a new mutant human cell line unresponsive to alpha and beta interferons. Mol. Cell. Biol., 1991, 11, 4189-4195.
84. 84. Müller, U., Steinhoff, U., Reis, L. F., Hemmi, S., Pavlovic, J., Zingernagel, R. M. and Aguet, M., Functional role of type I and type II interferons in antiviral defense. Science, 1994, 264, 1918-1921.
85. 85. Meraz, M. A., White, J. M., Sheehan, K. C., Bach, E. A., Rodig, S. J., Dighe, A. S., Kaplan, D. H., Riley, J. K., Greenlund, A. C., Campbell, D., Carver-Moore, K., DuBois, R. N., Clark, R., Aguet, M. and Schreiber, R. D., Targeted disruption of the Stat1 gene in mice reveals unexpected physiologic specificity in the JAK-STAT signalling pathway. Cell, 1996, 84, 431-442.
86. 86. Driggers, P. H., Ennist, D. L., Gleason, S. L., Mak, W.-H., Marks, M. S., Levi, B.-Z., Flanagan, J. R., Appella, E. and Ozzato, K., An Interferon γ-regulated protein that binds the interferon-inducible enhancer element of major histocompatibility complex class I genes. Proc. Natl. Acad. Sci. U.S.A., 1990, 87, 3743-3747.
87. 87. Weisz, A., Marx, P., Sharf, R., Appella, E., Driggers, P. H., Ozato, K. and Levi, B.-Z., Human interferon consensus sequence binding protein is a negative regulator of enhancer elements common to interferon-inducible genes. J. Biol. Chem., 1992, 267, 25589-25596.
88. 88. Bovolenta, C., Driggers P. H., Marks, M. S., Medin, J. A., Politis, A. D., Vogel, D. N., Levy, D. E., Sakaguchi, K., Appella, E., Coligan, J. E. and Ozato, K., Molecular interactions between interferon consensus sequence binding protein and members of the interferon regulatory factor family. Proc. Natl. Acad. Sci. U.S.A., 1994, 91, 5046-5050.
89. 89. Nelson, N., Marks, M. S., Driggers, P. H. and Ozato, K., Interferon consensus sequence binding protein, a member of the interferon regulatory factor family, suppresses interferon-induced gene transcription. Mol. Cell. Biol., 1993, 13, 588-599.
90. 90. Sharf, R., Azriel, A., Lejbkowicz, F., Winograd, S. S., Ehrlick, R. and Levi, B.-Z., Functional domain analysis of interferon consensus sequence binding protein (ICSBP) and its association with interferon regulatory factors. J. Biol. Chem., 1995, 270, 13063-13069.
91. 91. Thornton, A. M., Ogryzko, V. V., Dent, A., Sharf, R., Levi, B.-Z., Kanno, Y., Staudt, L. M., Howard, B. H. and Ozato, K., A dominant negative mutant of an IFN regulatory factor family protein inhibits both type I and type II IFN-stimulated gene expression and antiproliferative activity of IFNs. J. Immunol., 1996, 157, 5145-5154.
92. 92. Brass, A. L., Kehrli, E., Eisenbeis, C. F., Storb, U. and Singh, H., Pip, a lymphoid-restricted IRF, contains a regulatory domain that is important for autoinhibition and ternary complex formation with the Ets factor PU.1. Genes Dev., 1996, 10, 2335-2347.
93. 93. Holtschke, T., Löhler, J., Kanno, Y., Fehr, T., Giese, N., Rosenbauer, F., Lou, J., Knobeloch, K.-P., Gabriele, L., Waring, J. F., Bachmann, M. F., Zingernagel, R. M., Morse, III, H. C., Ozato, K. and Horak, I., Immunodeficiency and chronic myelogenous leukemia-like syndrome in mice with a targeted mutation of the ICSBP gene. Cell, 1996, 87, 307-317.
94. 94. Thornton, A. M., Buller, R. M. L., DeVico, A. L., Wang, I.-M. and Ozato, K., Inhibition of human immunodeficiency virus type I and vaccinia virus infection by a dominant negative factor of the interferon regulatory factor family expressed in monocytic cells. Proc. Natl. Acad. Sci. U.S.A., 1996, 93, 383-387.
95. 95. El Kharroubi, A. and Verdin, E., Protein-DNA interactions within DNase I-hypersensitive sites located downstream of the HIV-1 promoter. J. Biol. Chem., 1994, 269, 19916-19924.
96. 96. Liang, C., Li, X., Quan, Y., Laughrea, M., Kleiman, L., Hiscott, J. and Wainberg, M. A., Sequence elements downstream of the human immunodeficiency virus type 1 long terminal repeat are required for efficient viral gene transcription. J. Mol. Biol., 1997, 272, 167-177.
97. 97. van Lint, C., Amella, C. A., Emilani, S., John, M., Jie, T. and Verdin, E., Transcription factor binding sites downstream of the human immunodeficiency virus type 1 transcription start site are important for virus infectivity. J. Virol., 1997, 71, 6113-6127.
98. 98. Eisenbeis, C. F., Singh, H. and Storb, U., Pip, a novel IRF family member, is a lymphoid-specific, PU.1-dependent transcriptional activator. Genes Dev., 1995, 9, 1377-1387.
99. 99. Crepieux, P., Coll, J. and Stehelin, D., The Ets family of proteins: weak modulators of gene expression in quest for transcriptional partners. Crit. Rev. Oncogen., 1994, 5, 615-638.
100. 100. Matsuyama, T., Grossman, A., Mittrücker, H.-W., Siderovski, D. P., Kiefer, F., Kawakami, T., Richardson, C. D., Taniguchi, T., Yoshinaga, S. K. and Mak, T. W., Molecular cloning of LSIRF, a lymphoid-specific member of the inteferon regulatory factor family that binds the interferon-stimulated response element (ISRE). Nucl. Acid Res., 1995, 23, 2127-2136.
101. 101. Yamagata, T., Nishida, J., Tanaka, T., Sakai, R., Mitani. K., Yoshida, M., Taniguchi, T., Yazaki, Y. and Hirai, H., A novel interferon regulatory factor family transcription factor, ICSAT/Pip/LSIRF, that negatively regulates the activity of interferon-regulated genes. Mol. Cell. Biol.. 1996, 16, 1283-1294.
102. 102. Hiscott, J., Petropoulos, L. and Lacoste, J., Molecular interactions between HTLV-1 Tax protein and the NF-κB/IκB transcription complex. Virol., 1995, 214, 3-11.
103. 103. Mittrücker, H.-W., Matsuyama, T., Grossman, A, Kündig, T. M., Potter, J., Shahinian, A., Wakeham, A., Patterson, B., Ohashi, P. S. and Mak, T. W., Requirement for the transcription factor LSIRF/IRF4 for mature B and T lymphocyte function. Science, 1997, 275, 540-543.
104. 104. Schaefer, B. C., Paulson, E., Strominger, J. L. and Speck, S. H., Constitutive activation of Epstein-Barr Virus (EBV) nuclear antigen 1 gene transcription by IRF1 and IRF2 during restricted EBV latency. Mol. Cell. Biol., 1997, 17, 873-886.
105. 105. Nonkwello, C., Ruf, I. K. and Sample, J., The Epstein-Barr Virus EBNA-1 promoter Qp requires an initiator-like element. J. Virol., 1997, 71, 354-361.
106. 106. Grossman, A., Nicholl, J., Antonio L., Luethy, R., Duggs, S., Sutherland, G. R. and Mak, T., Characterization of IRF-7, a novel interferon regulatory factor (manuscript in preparation).
107. 107. Cha, Y. and Deisseroth, A. B., Human interferon regulatory factor 2 gene. J. Biol. Chem., 1994, 269, 5279-5287.
108. 108. Harada, H., Takahashi, E.-I., Itoh, S., Harada, K., Hori, T.-A. and Taniguchi, T., Structure and regulation of the human regulatory factor 1 (IRF-1) and IRF-2 genes: implications for a gene network in the interferon system. Mol. Cell. Biol., 1994, 14, 1500-1509.
109. 109. Pine, R., Canova, A. and Schindlet, C., Tyrosine phosphorylated p91 binds to a single element in the ISGF2/IRF-1 promoter to mediate induction by IFNα and IFNβ, and is likely to autoregulate the p91 gene. EMBO J., 1994, 13, 158-167.
110. 110. Kanno, Y., Kozak, C. A., Schindler, C., Driggers, P. H., Ennist, D. L., Gleason, S. L., Darnell, Jr. J. E. and Ozato, K., The genomic structure of the murine ICSBP gene reveals the presence of the gamma interferon-responsive element, to which an ISGF3α subunit (or similar) molecule binds. Mol. Cell Biol. 1993, 13, 3951-3963.
111. 111. Sims, S. H., Cha, Y., Romine, M. F., Gao, P.-Q., Gottlieb, K. and Deisseroth, A. B., A novel interferon-inducible domain: structural and functional analysis of the human interferon regulatory factor 1 gene promoter. Mol. Cell. Biol., 1993, 13, 690-702.
112. 112. Baeuerle, P. A. and Henkel, T., Function and activation of NF-κB in the immune system. Annu. Rev. Immunol., 1994, 12, 141-179.